Advocacy groups launch new services to match patients and trials

The Michael J. Fox Foundation is joining a lineup of patient advocacy groups that has been setting up new sites to match patients with drug studies. has been offering a window to drug studies, notes The Wall Street Journal, which covered the trend. But with 125,000 studies listed for 179 countries, the site demands considerable patience from patients who use it to find experimental therapies for which they may like to volunteer.

These new services could be a significant help for drug developers, which often run into trouble recruiting the patients they need for a clinical trial. Tufts experts have concluded that fewer than half of all mid- and late-stage studies complete enrollment on time. A large minority require twice the time initially budgeted for the task.

- here's the story from The Wall Street Journal

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.